These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31111561)

  • 1. Plasma amino acid profiles in dogs with inflammatory bowel disease.
    Tamura Y; Ohta H; Kagawa Y; Osuga T; Morishita K; Sasaki N; Takiguchi M
    J Vet Intern Med; 2019 Jul; 33(4):1602-1607. PubMed ID: 31111561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does canine inflammatory bowel disease influence gut microbial profile and host metabolism?
    Xu J; Verbrugghe A; Lourenço M; Janssens GP; Liu DJ; Van de Wiele T; Eeckhaut V; Van Immerseel F; Van de Maele I; Niu Y; Bosch G; Junius G; Wuyts B; Hesta M
    BMC Vet Res; 2016 Jun; 12(1):114. PubMed ID: 27306031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease.
    Otoni CC; Heilmann RM; García-Sancho M; Sainz A; Ackermann MR; Suchodolski JS; Steiner JM; Jergens AE
    J Vet Intern Med; 2018 May; 32(3):999-1008. PubMed ID: 29624721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amino acid profile in 51 dogs with immunosuppressant-responsive enteropathy (IRE): a pilot study on clinical aspects and outcomes.
    Benvenuti E; Pierini A; Gori E; Bartoli F; Erba P; Ruggiero P; Marchetti V
    BMC Vet Res; 2020 Apr; 16(1):117. PubMed ID: 32321505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet indices as biomarkers for characterization and determination of severity in canine chronic enteropathy.
    Mehain SO; Haines JM; Lee PM
    Vet J; 2019 Jun; 248():37-41. PubMed ID: 31113560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
    Münster M; Hörauf A; Bilzer T
    Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical signs, duodenal histopathological grades, and serum high-mobility group box 1 concentrations in dogs with inflammatory bowel disease.
    Lee JH; Kim HS; Lee D; Yun T; Koo Y; Chae Y; Kang JH; Kang BT; Yang MP; Kim H
    J Vet Intern Med; 2021 Sep; 35(5):2205-2214. PubMed ID: 34480505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD11c+ cells are significantly decreased in the duodenum, ileum and colon of dogs with inflammatory bowel disease.
    Kathrani A; Schmitz S; Priestnall SL; Smith KC; Werling D; Garden OA; Allenspach K
    J Comp Pathol; 2011 Nov; 145(4):359-66. PubMed ID: 21592490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in serum amino acid concentrations in dogs with protein-losing enteropathy.
    Kathrani A; Allenspach K; Fascetti AJ; Larsen JA; Hall EJ
    J Vet Intern Med; 2018 May; 32(3):1026-1032. PubMed ID: 29604114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum calprotectin concentrations in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Jergens AE; Ackermann MR; Barr JW; Suchodolski JS; Steiner JM
    Am J Vet Res; 2012 Dec; 73(12):1900-7. PubMed ID: 23176415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlating Gastrointestinal Histopathologic Changes to Clinical Disease Activity in Dogs With Idiopathic Inflammatory Bowel Disease.
    Allenspach KA; Mochel JP; Du Y; Priestnall SL; Moore F; Slayter M; Rodrigues A; Ackermann M; Krockenberger M; Mansell J; ; Luckschander N; Wang C; Suchodolski J; Berghoff N; Jergens AE
    Vet Pathol; 2019 May; 56(3):435-443. PubMed ID: 30563436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum biomarkers of oxidative stress in dogs with idiopathic inflammatory bowel disease.
    Rubio CP; Martínez-Subiela S; Hernández-Ruiz J; Tvarijonaviciute A; Cerón JJ; Allenspach K
    Vet J; 2017 Mar; 221():56-61. PubMed ID: 28283081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship among plasma amino acids, C-reactive protein, illness severity, and outcome in critically ill dogs.
    Chan DL; Rozanski EA; Freeman LM
    J Vet Intern Med; 2009; 23(3):559-63. PubMed ID: 19645841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67/CD3 ratio in the diagnosis of chronic inflammatory enteropathy in dogs.
    Karlovits S; Manz A; Allenspach K; Walter I; Kummer S; Tichy A; Richter B; Burgener IA; Luckschander-Zeller N
    J Vet Intern Med; 2020 Jan; 34(1):92-97. PubMed ID: 31825538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment.
    Kalenyak K; Heilmann RM; van de Lest CHA; Brouwers JF; Burgener IA
    PLoS One; 2019; 14(4):e0215435. PubMed ID: 30990833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease.
    McCann TM; Ridyard AE; Else RW; Simpson JW
    J Small Anim Pract; 2007 Nov; 48(11):620-5. PubMed ID: 17608662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease.
    Konstantinidis AΟ; Pardali D; Adamama-Moraitou KK; Gazouli M; Dovas CI; Legaki E; Brellou GD; Savvas I; Jergens AE; Rallis TS; Allenspach K
    BMC Vet Res; 2020 Feb; 16(1):69. PubMed ID: 32087719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease.
    Minamoto Y; Otoni CC; Steelman SM; Büyükleblebici O; Steiner JM; Jergens AE; Suchodolski JS
    Gut Microbes; 2015; 6(1):33-47. PubMed ID: 25531678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.